131 related articles for article (PubMed ID: 2781890)
1. [Is it really necessary to discontinue hormonal contraceptives before carrying out a planned operation?].
Zentralbl Gynakol; 1989; 111(11):771-80. PubMed ID: 2781890
[No Abstract] [Full Text] [Related]
2. [Hormonal contraception--thromboembolic disorders and surgical risk (author's transl)].
Göretzlehner G; Frick G; Frick U
Zentralbl Chir; 1976; 101(18):1103-11. PubMed ID: 983453
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery?
Shiffman MA
J Womens Health (Larchmt); 2003 Nov; 12(9):853-5; discussion 855. PubMed ID: 14670164
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and hypercoagulation.
Petitti DB
Clin Adv Hematol Oncol; 2006 Nov; 4(11):813-5. PubMed ID: 17143250
[No Abstract] [Full Text] [Related]
5. [Proper education for the patient! Risk of thromboembolism with oral contraception].
Wenderlein JM
MMW Fortschr Med; 2000 Feb; 142(7):38-9. PubMed ID: 10832333
[No Abstract] [Full Text] [Related]
6. [19-year-old patient with thromboembolism caused by oral contraception].
Pihusch R; de Coutre P; Salat C; Göhring P; Poley S; Hiller E
Internist (Berl); 1996 Nov; 37(11):1163-6. PubMed ID: 9036113
[No Abstract] [Full Text] [Related]
7. [Hormones and hemostasis].
Winkler UH
Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):M39-42. PubMed ID: 8188004
[No Abstract] [Full Text] [Related]
8. [Results of the "light pill" action].
Gerstner GJ; Kunze M
Gynakol Rundsch; 1989; 29 Suppl 2():469-71. PubMed ID: 2613077
[No Abstract] [Full Text] [Related]
9. [A new test system for evaluating the risk of thromboembolism in the use of hormonal contraceptives].
Pechlaner C; Kunz F; Tabarelli M; Sölder E; Zwierzina WD; Reitsamer R; Koch R
Gynakol Rundsch; 1989; 29 Suppl 2():312-4. PubMed ID: 2613036
[No Abstract] [Full Text] [Related]
10. [Phlebology from a gynecological viewpoint].
During R; Schwarzlos G
Z Arztl Fortbild (Jena); 1980 Nov; 24(21):1003-4. PubMed ID: 7233973
[No Abstract] [Full Text] [Related]
11. [Pregnancy, lactation, oral contraceptives, long distance travel. Discussion of prevention of thromboembolism prevention].
Kirchmayr K; Mani H; Lindhoff-Last E
Pharm Unserer Zeit; 2004; 33(3):230-5. PubMed ID: 15208911
[No Abstract] [Full Text] [Related]
12. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
13. [Contraception in risk patients. Discussion].
Detering K; Hartmann E
Med Welt; 1980 Dec; 31(49):1805-6. PubMed ID: 7207122
[No Abstract] [Full Text] [Related]
14. Oral contraceptives and venous thromboembolism.
Savage RL
N Z Med J; 1997 Mar; 110(1040):109. PubMed ID: 9137318
[No Abstract] [Full Text] [Related]
15. Family history and risk of venous thromboembolism with oral contraception. Family history is important tool.
Vandenbroucke JP; van der M eer FJ; Helmerhorst FM; Rosendaal FR
BMJ; 2001 Sep; 323(7315):752. PubMed ID: 11675729
[No Abstract] [Full Text] [Related]
16. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
[No Abstract] [Full Text] [Related]
17. Risks of oral contraceptives.
Roberts H; McCowan L; Roke C; Liddell H; Batcheler L; Thakurdas N; Wilson J
N Z Med J; 1987 Jul; 100(827):430-1. PubMed ID: 3452077
[No Abstract] [Full Text] [Related]
18. [Summary of the practice guideline 'Hormonal contraception' (second revision) from the Dutch College of General Practitioners].
Siemons GH
Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1999. PubMed ID: 15524140
[No Abstract] [Full Text] [Related]
19. Venous thromboembolism in relation to oral contraceptive use.
Helmrich SP; Rosenberg L; Kaufman DW; Strom B; Shapiro S
Obstet Gynecol; 1987 Jan; 69(1):91-5. PubMed ID: 3796927
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
Bounameaux H; de Moerloose P; Campana A
Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
